Quick Answer
BioAtla, Inc. reported Total Assets of $13.83 million for the year ending 2025.
- BioAtla, Inc. showed a decrease of -73.6% in Total Assets from 2024 to 2025.
- This data is from BioAtla, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $229.09 million | Q2 2021: $216.71 million | Q3 2021: $277.58 million | Q1 2022: $230.65 million | Q2 2022: $213.50 million | Q3 2022: $189.11 million | Q1 2023: $204.55 million | Q2 2023: $179.64 million | Q3 2023: $151.36 million | Q1 2024: $89.20 million | Q2 2024: $68.64 million | Q3 2024: $62.24 million | Q1 2025: $38.29 million | Q2 2025: $27.13 million | Q3 2025: $15.91 million.
- Over the full 6 years of available data (2020 to 2025), BioAtla, Inc.'s Total Assets has declined by 94.4%.
- Historical annual values: Fiscal year 2025: $13.83 million | Fiscal year 2024: $52.42 million | Fiscal year 2023: $119.66 million | Fiscal year 2022: $225.74 million | Fiscal year 2021: $254.42 million | Fiscal year 2020: $244.94 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: